IBM Receives FedRAMP Authorization for its Envizi ESG Data Capture, Analysis and Reporting Solution

2024-10-25 IBM HaiPress

WASHINGTON,Oct. 24,2024 --IBM (NYSE: IBM) today announced that its Envizi environmental,social,and governance (ESG) Suite received Federal Risk and Authorization Management Program (FedRAMP) authorization. Designed to create a single,trusted system of record for all ESG data,the IBM Envizi ESG Suitehelps organizations automate the capture and management of ESG data for enhanced analysis,reporting and opportunity identification. IBM Envizi is available to federal agencies on the FedRAMP Marketplacein the Analytics and Data Management business categories.


IBM Corporation logo.

With more than 300,000 buildings,four million employees,640 million acres of public land,and $700 billion in annual purchases of goods and services,the federal government's role in championing ESG principles continues to expand. While new reporting frameworks like the Securities and Exchange Commission's (SEC) for climate disclosuresare prompting agencies to be more diligent and transparent in how they collect,analyze and report ESG data,obstacles like poor data quality,data fragmentation and complexity,alongside ever-changing reporting regulations,could make measuring progress and reporting outcomes a challenge. By automating ESG data collection and analysis and providing a solution to help streamline the reporting process,IBM Envizi is designed to help agencies begin to overcome these obstacles by minimizing errors,reducing time spent sorting through data,and providing the data insights that can turn into actionable strategies.

"ESG has an impact on government and government has an impact on our broader society and citizens," said Vanessa Hunt,General Manager,Technology,U.S. Federal Market for IBM. "When considering the federal government's size and scale,there's an opportunity for agencies to lead by example. Now that our Envizi ESG Suite has received FedRAMP authorization,federal agencies can take advantage of its capabilities with the confidence that their ESG data are secured and protected."

About IBM


IBM is a leading provider of global hybrid cloud and AI,and consulting expertise. We help clients in more than 175 countries capitalize on insights from their data,streamline business processes,reduce costs and gain the competitive edge in their industries. Thousands of government and corporate entities in critical infrastructure areas such as financial services,telecommunications and healthcare rely on IBM's hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly,efficiently and securely. IBM's breakthrough innovations in AI,quantum computing,industry-specific cloud solutions and consulting deliver open and flexible options to our clients. All of this is backed by IBM's long-standing commitment to trust,transparency,responsibility,inclusivity and service.

Media contact


Banks Willis


banks.willis@ibm.com

Disclaimer: This article is reproduced from other media. The purpose of reprinting is to convey more information. It does not mean that this website agrees with its views and is responsible for its authenticity, and does not bear any legal responsibility. All resources on this site are collected on the Internet. The purpose of sharing is for everyone's learning and reference only. If there is copyright or intellectual property infringement, please leave us a message.

Newest

1The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The First Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

2The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

The Second Series of the World Chinese Medicine Forum in 2025 Concludes Successfully

3Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Singapore College of Traditional Chinese Medicine Sign Strategic Cooperation Framework Agreement on TCM Education and Exchange

4Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

Tianjiang Pharmaceutical, a Subsidiary of China TCM, Participates in the 4th CACM Specialized Disease Collaboration Platform Annual Conference & 10th Jiangsu Traditional Chinese Medicine Academic Conference

5Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

Tianjiang Pharmaceutical, a Subsidiary of China TCM, and Federation of Chinese Medicine & Acupuncture Societies of Australia Sign Strategic Cooperation Framework Agreement

6MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

MEXC Claims Dual Wins at BeInCrypto 100 Awards as Best Centralized Exchange and Best Exchange in LATAM

©copyright 2009-2020 Singapore Info Map